Navigation Links
Prix Galien USA Recognizes Biotech, Pharmaceutical Industries for Innovative Medical Treatments
Date:9/25/2008

Awards for best biotechnology and best pharmaceutical agents honored outstanding drugs for treating cancer, HIV/AIDS and other life-altering diseases

NEW YORK, Sept. 25 /PRNewswire-USNewswire/ --- Prix Galien USA 2008 (http://www.prix-galien-usa.com) last night recognized the innovations and ingenuities of biotechnological and pharmaceutical companies and researchers for the development of drugs that address pervasive illness and diseases including cancer, HIV/AIDS, hypertension and others.

At the ceremony, Sheldon Segal, distinguished scientist at the Population Council, received the Pro Bono Humanum Award for spearheading an innovative, collaborative and charitable coalition approach toward developing and distributing implantable hormone delivery systems used for birth control and family planning, improving the quality of life of more than 8 million women worldwide. The award, which was given by Elie Wiesel, also recognized other coalition members the late Judah Folkman of Harvard University, the Rockefeller Brothers Foundation, Dow-Corning and Wyeth for their contributions to this science-based global effort to improve reproductive health, especially in underserved countries.

"The therapeutic agents recognized by Prix Galien USA represent the best of the best, impacting such conditions as cancer, HIV/AIDS and human debility, and serve as examples of what the biopharmaceutical industry can do to improve the human condition," said Gerald Weissmann, M.D., Prix Galien USA committee chair, New York University professor emeritus and editor-in-chief of The FASEB Journal. "We are living in the midst of a biological revolution and the breakthrough agents honored by the Prix Galien USA illustrate the substantial research and development necessary to bring the fruits of that revolution in molecular medicine to the clinic."

The Prix Galien USA 2008 winners include:

Best Pharmaceutical Agent (Small Molecule)

-- Selzentry(TM) Hidden List (Pfizer Inc.) -- This treatment is

used to treat a strain of HIV called "CCR5-tropic HIV-1

detectable," a strain that was previously resistant to other

therapies. Selzentry works by preventing HIV from binding to T-cells, a

necessary step for the virus to spread and replicate throughout the

body.

-- Isentress(R) (Merck & Co., Inc.) -- Isentress is the first drug in a

new class of HIV medications called "integrase inhibitors,"

that works by preventing HIV from taking over human cells and stopping

viral replication.

Best Biotechnology Agent

-- Soliris(TM) (Alexion Pharmaceuticals, Inc.) -- This is the first and

only FDA-approved drug to treat Paroxysmal Nocturnal Hemoglobinuria, a

rare disease that usually leads to a painful death by age 10.

-- INFUSE(R) (Wyeth) -- Hidden List INFUSE is a bone graft

device that incorporates a synthesized therapeutic protein to promote

bone healing.

Special Therapeutic Development

-- The Celgene Corporation for Revlimid(R) -- Taken orally, this cancer

medication primes the immune system for killing cancer cells.

The Prix Galien Award (http://www.prix-galien-usa.com) recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines, and is considered the industry's highest accolade for pharmaceutical research and development -- equivalent to the Nobel Prize. Prix Galien was first established in 1970 by French pharmacist Roland Mehl and was inaugurated in the United States in September 2007. The Prix Galien USA awards committee of 11 individuals includes seven Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals.


'/>"/>
SOURCE Prix Galien USA
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Prix Galien USA Welcomes Eighth Nobel Laureate to its Prestigious Award Committee
2. U.S. Chamber Recognizes NutraCea for Strong Corporate Stewardship
3. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
4. State of Ohio Recognizes Cincinnati Sub-Zero for Excellence in International Sales
5. Presidents Award Recognizes Hospitals Response to Bridge Collapse
6. SFMS David Perlman Award For Excellence in Medical/Health Reporting Recognizes Local Reporters
7. PA Agriculture Official Recognizes Healthy Garden at Lehigh County School
8. AVMA Recognizes Public Veterinarians Urges Congressional Action
9. President Recognizes Sharp HealthCare With 2007 Malcolm Baldrige National Quality Award at White House
10. Sierra Tucson Recognizes Professionals at Gratitude for Giving Breakfast
11. EPA Recognizes Fort Wayne Community Schools for Reducing Diesel Emissions From Its School Buses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... -- Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an ... Puerto Rico , where the company ... Following a comprehensive onsite assessment, ... damage, temporary loss of power and minimal water damage ... operations have resumed, and the company expects to return ...
(Date:10/10/2017)... 2017   West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today shared the results of a study ... the intradermal administration of polio vaccines. The study results ... May 2017 by Dr. Ondrej Mach , Clinical ... Organization (WHO), and recently published in the journal ...
(Date:10/5/2017)...  In response to the nationwide opioid epidemic, ... (AAOMS) released prescribing recommendations that urge ibuprofen – ... a first-line therapy to manage a patient,s acute ... Recognizing the value and importance of the ... Acute and Postoperative Pain Management" stresses that practitioners ...
Breaking Medicine Technology: